EVM18001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EVM18001, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases [NA]